Browsing: eli lilly
AI chip maker Nvidia’s fresh partnerships with Eli Lilly and Johnson & Johnson point to a broader trend in the…
Gallup released a survey this week showing that the obesity rate among US adults has fallen to 37% this year, a significant…
It’s tough to say for sure which growth stocks will be winners without a crystal ball. But investors may wish…
Eli Lilly’s decision to sell its obesity drug Zepbound directly to patients for $499 per month—well below the $2,000 list…
Novo Nordisk A/S ousted Chief Executive Officer Lars Fruergaard Jorgensen as the drugmaker struggles with growing competition for its obesity…
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…
Hannah Richardson, 24, undergoes a brain scan as part of the Primary Prevention Trial for Alzheimer’s disease led by Washington…
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication…
The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health…